RecruitingNot applicableNCT03727555
IT and IV Lentiviral Gene Therapy for X-ALD
Studying X-linked adrenoleukodystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Intervention
- Intrathecal and intravenous LV gene therapy(genetic)
- Enrollment
- 30 enrolled
- Eligibility
- 1-60 years · All sexes
- Timeline
- 2025 – 2028
Study locations (1)
- Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03727555 on ClinicalTrials.govOther trials for X-linked adrenoleukodystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06178120Disease Progression in Women With X-linked AdrenoleukodystrophyMinoryx Therapeutics, S.L.
- RECRUITINGNCT05939232Registry of X-linked AdrenoleukodystrophyBeijing Tiantan Hospital
- RECRUITINGNCT04675749Quality of Life in Women with X-linked AdrenoleukodystrophyLeipzig University Medical Center